FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Collections Drugs and Devices, 1940-1963 ✖Remove constraint Collections: Drugs and Devices, 1940-1963 Titles 4343. Misbranding of dextroamphetamine sulfate tablets and pentobarbital sodium capsules. U. S. v. Travis E. Shankle (Lyons Drug Co.), Herbert C. Rehnberg, and Henry Rozeboom. Plea of nolo contendere by Defend ant Shankle and pleas of guilty by Defendants Rehnberg and Rozeboom. Fine of $200 against Defendant Shankle, $150 against Defendant Rozeboom, and $100 against Defendant Rehnberg, plus costs. ✖Remove constraint Titles: 4343. Misbranding of dextroamphetamine sulfate tablets and pentobarbital sodium capsules. U. S. v. Travis E. Shankle (Lyons Drug Co.), Herbert C. Rehnberg, and Henry Rozeboom. Plea of nolo contendere by Defend ant Shankle and pleas of guilty by Defendants Rehnberg and Rozeboom. Fine of $200 against Defendant Shankle, $150 against Defendant Rozeboom, and $100 against Defendant Rehnberg, plus costs. Issue Dates April 1955 ✖Remove constraint Issue Dates: April 1955

Refine by:

  • 4343. Misbranding of dextroamphetamine sulfate tablets and pentobarbital sodium capsules. U. S. v. Travis E. Shankle (Lyons Drug Co.), Herbert C. Rehnberg, and Henry Rozeboom. Plea of nolo contendere by Defend ant Shankle and pleas of guilty by Defendants Rehnberg and Rozeboom. Fine of $200 against Defendant Shankle, $150 against Defendant Rozeboom, and $100 against Defendant Rehnberg, plus costs.1